Added to YB: 2017-03-15
Pitch date: 2017-03-15
ENTA:US [bullish]
Enanta Pharmaceuticals, Inc.
-73.3%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases.
Market Cap
$336.2M
Pitch Price
$55.16
Price Target
N/A
Dividend
N/A
EV/EBITDA
-4.53
P/E
-2.79
EV/Sales
5.23
Sector
Biotechnology
Category
N/A
Show full summary:
ENANTA PHARMACEUTICALS INC COM ENTA:US
A summary for this pitch has not been created yet.
Read full article (0 min)